UBS Lux Equity Fund Biotech USD vs Berkshire Hathaway

UBS Lux Equity Fund Biotech USD vs Berkshire Hathaway

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Berkshire Hathaway

  • Security

    Berkshire Hathaway Inc Class A

  • ISIN

    US0846701086

  • Holdings

    9

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Berkshire Hathaway, we have 15 holdings where Apple is the largest holding (21.1), followed by American Express (14.3) and Coca-Cola (11.2).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Berkshire Hathaway.

UBS Lux Equity Fund Biotech USD Berkshire Hathaway
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Apple Inc
USA
21.1 %
2. Moderna Inc
9.21 %
2. American Express Co
USA
14.3 %
3. Gilead Sciences Inc
USA
4.66 %
3. Coca-Cola Company
USA
11.2 %
4. BioNTech SE
4.13 %
4. Bank of America Corp
USA
9.7 %
5. Karuna Therapeutics Inc
3.75 %
5. Chevron Corp
USA
6.6 %
- 6. Moody's Corp
USA
4 %
- 7. Occidental Petroleum Corp
USA
3.9 %
- 8. Kraft Heinz Co
USA
3.7 %
- 9. Chubb Ltd
USA
3 %

The list of fund holdings was last updated on September 10, 2025.